脂肪性肝病中的线粒体改变
本文综述肝线粒体在肥胖、2型糖尿病及外源性物质相关脂肪性肝病中的改变。线粒体脂肪酸氧化及氧化磷酸化受损驱动氧化应激,是人间质性肝炎的重要特征,而肝线粒体亦可适应代谢环境防止甘油三酯和脂毒性物质蓄积。近期临床研究评估饮食或减重手术对肝线粒体的影响,线粒体正成为非酒精性脂肪性肝病的治疗靶点。
要点
- 肝线粒体功能异常如脂肪酸氧化和氧化磷酸化受损,驱动氧化应激,是人间质性肝炎的重要特征。
- 肝线粒体可灵活适应周围代谢条件,防止肥胖时甘油三酯和脂毒性物质蓄积。
- 代谢病相关(脂毒性)与酒精相关肝病常共存,需更好理解二者在疾病进展中的相互作用与增强效应。
核心结论
- 肝线粒体功能异常(脂肪酸氧化和氧化磷酸化受损)驱动氧化应激,是人间质性肝炎的重要特征;肝线粒体亦可适应代谢环境防止甘油三酯和脂毒性物质蓄积;线粒体正成为非酒精性脂肪性肝病的治疗靶点。
研究设计与样本
- 综述,总结肝线粒体与肥胖、2型糖尿病及外源性物质相关脂肪性肝病有关的当前认识。
主要发现
- 脂肪酸氧化和氧化磷酸化受损等线粒体功能异常驱动氧化应激,已被认定为人间质性肝炎的重要特征。
- 肝线粒体可灵活适应周围代谢条件,防止肥胖时甘油三酯和脂毒性物质蓄积。
- 外源性物质研究经验为肝线粒体调控提供了重要见解。
- 代谢病相关(脂毒性)与酒精相关肝病常共存,需更好理解二者在疾病进展中的相互作用与增强效应。
- 近期临床研究评估了饮食或减重手术对肝线粒体的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fatty liver diseases can result from common metabolic diseases, as well as from xenobiotic exposure and excessive alcohol use, all of which have been shown to exert toxic effects on hepatic mitochondrial functionality and dynamics. Invasive or complex methodology limits large-scale investigations of mitochondria in human livers. Nevertheless, abnormal mitochondrial function, such as impaired fatty acid oxidation and oxidative phosphorylation, drives oxidative stress and has been identified as an important feature of human steatohepatitis. On the other hand, hepatic mitochondria can be flexible and adapt to the ambient metabolic condition to prevent triglyceride and lipotoxin accumulation in obesity. Experience from studies on xenobiotics has provided important insights into the regulation of hepatic mitochondria. Increasing awareness of the joint presence of metabolic disease-related (lipotoxic) and alcohol-related liver diseases further highlights the need to better understand their mutual interaction and potentiation in disease progression. Recent clinical studies have assessed the effects of diets or bariatric surgery on hepatic mitochondria, which are also evolving as an interesting therapeutic target in non-alcoholic fatty liver disease. This review summarises the current knowledge on hepatic mitochondria with a focus on fatty liver diseases linked to obesity, type 2 diabetes and xenobiotics.
引用
- Fromenty B, Roden M. Mitochondrial alterations in fatty liver diseases. J Hepatol. 2022. PMID: 36209983. doi:10.1016/j.jhep.2022.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。